Ivanti Neurons for Patch Management is a commercial vulnerability assessment solution by Ivanti. Sherlock PowerShell Script is a free vulnerability assessment solution. Features, integrations, deployment and the company behind each one, side by side.
Cloud-native patch management with risk-based prioritization and automation
Powerful PowerShell script for identifying missing software patches for local privilege escalation vulnerabilities.
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
Ivanti Neurons for Patch Management fits if you want a cloud product.
Sherlock PowerShell Script fits if you need to run it on your own servers, you are a startup, you need a free product and you want an open-source product.
Common questions when comparing Ivanti Neurons for Patch Management vs Sherlock PowerShell Script for vulnerability assessment.
Ivanti Neurons for Patch Management: Cloud-native patch management with risk-based prioritization and automation. Built by Ivanti.
Sherlock PowerShell Script: Powerful PowerShell script for identifying missing software patches for local privilege escalation vulnerabilities.
The table above shows where their features, integrations, deployment and company size fit differ.
Ivanti Neurons for Patch Management is made by Ivanti. Sherlock PowerShell Script is open-source with 1,997 GitHub stars. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. Ivanti Neurons for Patch Management and Sherlock PowerShell Script are both Vulnerability Assessment products, and both cover Patch Management. Key differences: Ivanti Neurons for Patch Management is Commercial while Sherlock PowerShell Script is Free, Sherlock PowerShell Script is open-source. Use the table above to see where features, deployment and company size fit differ.
No Vulnerability Assessment shortlist yet. This is the closest one.
Updated 2026-11-02
See the shortlist
